The Nitrosamine Implementation Oversight Group (NIOG) was set up (in February 2021) by the European medicines regulatory network to oversee the harmonised implementation of the Article 5(3) CHMP opinion on nitrosamines in human medicinal products and to provide progress updates to the European Medicines Regulatory Network Authorities. The Terms of Reference of NIOG, containing scope, membership, oganisational and administrative support, mandate and workplan are now available, click here.
April 14, 2021